Experts Forecast Cancer Research and Treatment Advances in 2026
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
From July 1 to September 30, 2025, the FDA issued eight new oncology approvals, expanding treatment options for patients...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
The opening session from the AACR Science of Cancer Health Disparities conference highlighted how perseverance and adversity have informed...
Richard and Michelle Schlueter attended the Rally for Medical Research to advocate for NIH funding after budget cuts delayed...
A workshop hosted by AACR and FDA explored novel clinical trial oncology endpoints and considerations for their validation and...
Adwoa Bemah Boamah Mensah, PhD, received a BIG Cat grant from the AACR to help her efforts to improve...
Researchers are helping advance ovarian cancer care with breakthroughs that are reshaping treatment and early detection approaches.
Cancer survivors profiled over the past 15 years in the AACR Cancer Progress Reports shared updates on their lives...
Elizabeth M. Jaffee, Timothy R. Rebbeck, and Andrea Cercek spoke about the AACR's conference on the rise of early-onset...
The second AACR Childhood Cancer Predisposition Workshop gathered experts from around the world to refine surveillance strategies, expanding recommendations...